Charcot-Marie-Tooth disease X-linked dominant 1 (often called CMTX1) is a genetic nerve disease. It mainly affects the peripheral nerves, which are the long nerves that carry signals from the spinal cord to the muscles and skin. These nerves help you move and feel. In this disease, the nerves slowly get weak and work less well over time.NCBI+1 CMTX1 is caused by harmful changes (mutations) in a gene called GJB1. This gene tells the body how to make a protein called connexin 32, which sits in the “myelin sheath.” Myelin is the insulating layer around nerves, and it helps messages travel quickly and smoothly. When connexin 32 does not work, the nerve insulation is damaged, and signals move slowly or are lost.NCBI+2Muscular Dystrophy Association+2
Charcot-Marie-Tooth disease X-linked dominant 1 (CMTX1) is a rare inherited nerve disease caused by changes (mutations) in the GJB1 gene, which makes a protein called connexin-32. Connexin-32 helps nerve-support cells (Schwann cells) talk to each other and maintain the myelin covering around nerves in the arms and legs. When GJB1 does not work properly, the myelin becomes damaged, nerve signals slow down, and muscles in the feet, legs, hands, and sometimes forearms become weak and thin over time. This slowly affects walking, balance, and fine hand movements. There is no cure yet, but supportive treatment with therapies, braces, and sometimes surgery can greatly improve daily life and independence. Wikipedia+2PMC+2
CMTX1 is called X-linked dominant because the faulty gene is on the X chromosome. One copy of the changed gene is enough to cause disease. Boys and men usually have more severe problems, because they have only one X chromosome. Girls and women can also be affected but often have milder signs or sometimes no clear symptoms at all.NCBI+2Orpha+2
Most people with CMTX1 start to notice problems in childhood or teenage years. The most common early signs are weakness in the feet and lower legs, trouble running, frequent ankle sprains, and changes in the shape of the feet, such as high arches. Over many years, weakness can move slowly upward to the hands and lower arms.Genetic Rare Diseases Center+1
Some people with CMTX1 also have short, sudden episodes that look like a “mini-stroke.” They can have temporary weakness, difficulty speaking clearly, or other brain-related symptoms. These episodes usually get better, but they show that CMTX1 can affect both the peripheral nervous system and the central nervous system (CNS) in some people.NCBI+2Frontiers+2
Other Names and Simple Types
This disease is known by several other names. All of these describe the same or very closely related conditions:
-
X-linked Charcot-Marie-Tooth disease type 1
-
CMTX1 or CMT1X
-
GJB1-related Charcot-Marie-Tooth neuropathy
-
X-linked dominant Charcot-Marie-Tooth neuropathy 1
-
X-linked hereditary motor and sensory neuropathy (X-linked HMSN)
-
Connexin 32-related neuropathy
Doctors also use simple clinical “types” inside CMTX1 based on how it looks in real life:
-
Classic CMTX1 with peripheral neuropathy only – The person has slowly progressive weakness and sensory loss in the hands and feet, but no clear brain involvement.
-
CMTX1 with central nervous system episodes – The person has the usual peripheral nerve problems and also has short “stroke-like” attacks, with sudden weakness or trouble speaking, which then improve.NCBI+2Frontiers+2
-
Early-onset CMTX1 – Symptoms start in early childhood, sometimes before school age, with very noticeable walking problems and foot deformities.
-
Late-onset CMTX1 – Symptoms start in adulthood, often milder, and may be missed or blamed on “normal aging” at first.NCBI+1
-
CMTX1 in females (variable expression) – Some women have clear weakness and foot changes, others have only mild signs on examination, and some may be almost symptom-free, even though they carry the gene change.Orpha+1
Causes and Risk Factors
In reality, the main cause of CMTX1 is always a harmful change in the GJB1 gene. All other “causes” below are either types of that gene change or factors that influence how strong the disease looks.
-
Pathogenic mutation in the GJB1 gene
The basic cause is a disease-making mutation in GJB1 on the X chromosome. This mutation changes the instructions for connexin 32, so the protein does not work correctly in the myelin around nerves.NCBI+2Muscular Dystrophy Association+2 -
Missense mutation (single-letter change) in GJB1
Many people with CMTX1 have a missense mutation, where one DNA “letter” is swapped for another. This leads to one wrong amino acid in connexin 32. The protein is made, but it does not form normal channels between cells.Nature+1 -
Nonsense or frameshift mutation in GJB1
Some mutations introduce a stop signal too early or shift the reading frame. The result is a very short or unstable protein. The body may destroy this faulty protein, meaning there is almost no working connexin 32.Nature+1 -
Splice-site mutation in GJB1
Splice-site changes affect the way the gene’s pieces are joined together. The final message (mRNA) is abnormal, so the protein is built in the wrong shape and cannot carry out its job inside myelin cells.Frontiers+1 -
Promoter or regulatory-region mutation
Some mutations are not in the coding part of GJB1 but in the promoter or regulatory regions. These changes can reduce how much connexin 32 is made, so nerve cells do not have enough of the protein to keep myelin healthy.Frontiers+1 -
Large deletions or duplications that include GJB1
In some families, part of the X chromosome, including GJB1, is missing (deletion) or extra (duplication). Having too little or too much of the gene disrupts normal protein levels and causes neuropathy.Nature+1 -
Inheritance from a carrier mother
Because the gene is on the X chromosome, many affected boys inherit the mutation from their mother. She may be mildly affected or almost normal, but she can still pass the faulty gene to her children. -
De novo (new) mutation in the child
Sometimes the mutation happens for the first time in the egg or sperm, or early in the embryo. In this case, there is no family history, but the child still develops CMTX1.NCBI+1 -
X-linked dominant inheritance pattern
This pattern means a father with the mutation cannot pass it to his sons (boys get their Y from the father), but he will pass it to all his daughters. This pattern shapes which family members are at risk, which indirectly “causes” who becomes affected.Orpha+1 -
Skewed X-inactivation in females
In girls and women, one X chromosome is turned off in each cell. If the normal X is turned off more often, and the X with the mutation stays active, the woman can have stronger symptoms. If the reverse happens, she may have very mild or no symptoms.Orpha -
Loss of connexin 32 gap junction channels
Connexin 32 forms small channels between myelin cells. These channels let small molecules and ions pass from one part of the Schwann cell to another. Mutations in GJB1 mean these channels are missing or faulty, so myelin cannot support the nerve properly.Nature+1 -
Damage to myelin around peripheral nerves
Without healthy connexin 32, the myelin sheath becomes thin or irregular. This slows down nerve signals and can cause “conduction block,” where signals do not pass through at all. Over time, this myelin damage is one of the direct biological causes of weakness and sensory loss.PMC+1 -
Gradual loss of motor nerve axons
Long-term myelin damage can also injure the underlying axon, the central “wire” of the nerve. As motor axons are lost, muscles lose their nerve supply and slowly shrink and weaken.NCBI+1 -
Gradual loss of sensory nerve axons
Sensory fibers that carry touch, pain, and vibration also suffer chronic stress and damage. Loss of these axons causes numbness, tingling, and poor position sense. -
Fever or infection triggering CNS episodes
In some people with CMTX1, fever or infection seems to trigger sudden, short episodes of brain symptoms. The exact mechanism is not fully known, but it may relate to how the GJB1 mutation affects brain cells and their gap junctions under stress.Frontiers+1 -
High-altitude or low-oxygen stress
Some reports suggest that going to high altitude or having low oxygen may trigger brain events in CMTX1. The stressed brain tissue, already vulnerable because of connexin 32 problems, may not tolerate these conditions well.Wiley Online Library -
Intense physical stress or over-exertion
Very heavy exercise or sudden strong physical stress can temporarily increase nerve demands. In people with already fragile nerves, this may make weakness or fatigue more obvious, even though it does not change the gene itself. -
Poorly controlled diabetes
Diabetes can cause its own type of peripheral neuropathy. If a person with CMTX1 also has uncontrolled diabetes, the extra damage from high blood sugar can make symptoms much worse. -
Alcohol misuse or toxic exposure
Long-term heavy alcohol use and some industrial chemicals can harm nerves. In someone with CMTX1, these toxins can speed up weakness and sensory loss because the nerves are already vulnerable. -
Use of strongly neurotoxic medicines
Certain chemotherapy drugs (for example, vincristine) and some other medicines can damage nerves. Experts usually warn people with CMT to avoid such drugs when possible, because they can greatly worsen existing neuropathy.Charcot-Marie-Tooth Association+1
Remember: only the gene mutation truly “causes” CMTX1. The other factors mainly modify how severe or fast the disease looks.
Symptoms and Signs
-
Slowly progressive weakness in the feet and lower legs
The first sign in many people is that the muscles near the ankles and lower legs become weak. This makes it hard to push off the ground or lift the front of the foot. The change is slow, happening over years, not days.Genetic Rare Diseases Center+1 -
Foot drop and tripping
When the muscles that lift the front of the foot are weak, the toes drag on the ground. This is called “foot drop.” The person may trip often, especially when walking fast or on uneven ground.NCBI -
Frequent ankle sprains or twisting
Weak muscles and unstable ankles mean the foot can easily roll in or out. People with CMTX1 often report many ankle sprains, sometimes from minor steps or small bumps in the road. -
High-arched feet (pes cavus)
Many people develop high, stiff arches. The heel and the ball of the foot bear most of the weight. This foot shape is very common in hereditary neuropathies like CMT and is an important clue for doctors.Frontiers+1 -
Hammertoes or other toe deformities
The small muscles inside the foot become weak, while stronger muscles pull more than normal. This imbalance bends the toes, causing hammertoes or clawed toes. These can rub in shoes and cause pain or calluses. -
Thin lower legs (“inverted champagne bottle” legs)
Because the muscles in the lower legs slowly waste away, the calf area can look thin. The upper legs may still look normal, giving the shape that doctors sometimes call “inverted champagne bottle” legs.NCBI+1 -
Numbness or reduced feeling in toes and feet
Damage to sensory nerves leads to less feeling in the toes and feet. People may not notice small injuries or blisters. They might say their feet feel “dead” or “like walking on cotton.”NCBI+1 -
Tingling or “pins and needles” in feet or hands
Some people feel tingling, burning, or “pins and needles.” These abnormal feelings happen because damaged nerves send mixed or weak signals to the brain. -
Reduced or absent ankle reflexes
When the doctor taps the Achilles tendon with a hammer, the normal reflex is weak or missing. This is a classic sign of peripheral neuropathy and is very common in CMTX1.NCBI+1 -
Weakness and wasting of hand muscles
Over time, weakness can move upward and affect the small muscles of the hands. The base of the thumb may look hollow, and the fingers may seem bony. This shows that the nerves to the hands are also affected.NCBI+1 -
Difficulty with fine hand tasks
Because of hand weakness, tasks like buttoning clothes, turning keys, holding a pen, typing, or using a phone can become hard. People may drop objects or feel clumsy. -
Problems with balance, especially in the dark
Loss of position sense in the feet makes it hard for the brain to know where the body is in space. Balance can be much worse when the eyes are closed or in dim light, because vision can no longer help as much.NCBI -
Leg cramps or muscle pain with walking
Weak muscles have to work extra hard, which can lead to cramps and aching. Poor foot posture can also strain joints and tendons, adding to pain. -
Fatigue and tiredness
Everyday activities such as walking at school, climbing stairs, or doing chores can use more energy for someone with weak muscles. This extra effort can cause strong tiredness and the need for frequent rest. -
Brief “stroke-like” episodes in some patients
A small group of people with CMTX1 have sudden episodes of weakness, trouble speaking, or other brain symptoms. These episodes often improve over hours or days, but they can be scary. Brain scans may show temporary white matter changes.Frontiers+2PMC+2
If anyone has sudden new weakness or trouble speaking, they must get emergency medical care, because real stroke and other serious problems can look similar.
Diagnostic Tests
Doctors use several kinds of tests to diagnose CMTX1. No single test is enough by itself. Usually, doctors combine the clinical picture, nerve tests, and genetic testing.NCBI+2Charcot-Marie-Tooth Association+2
Physical Exam Tests
-
Detailed neurological examination
The neurologist checks muscle strength, sensation, reflexes, and coordination in all four limbs. They look for patterns typical of hereditary neuropathy, such as distal (far-away) weakness and reduced reflexes at the ankles. This exam gives the first strong clue that a peripheral neuropathy is present.NCBI -
Examination of foot and hand shape
The doctor inspects the feet for high arches, flat feet, or hammertoes, and the hands for muscle wasting. Typical foot deformities plus a family history strongly suggest a type of CMT like CMTX1. -
Gait and balance examination
The person is asked to walk normally, walk on toes, walk on heels, and stand with feet together. The doctor watches for foot drop, ankle instability, and unsteady walking. Difficulty walking on heels is a common early sign of weakness in the muscles that lift the foot.NCBI -
Cranial nerve and speech examination
Because some patients can have brain involvement, the doctor also checks eye movements, facial muscles, and speech clarity. Any sign of slurred speech or facial weakness may suggest a CNS episode and may lead to further brain testing.NCBI+2Frontiers+2
Manual (Bedside) Tests
-
Manual muscle strength testing (MRC grading)
The doctor or therapist pushes against different muscle groups (for example, asking the person to pull the foot up or push it down) and grades strength from 0 to 5. This simple, hands-on test shows which muscles are weak and how severe the weakness is. -
Bedside sensory testing (touch, pin, vibration)
Using cotton, a pin, and a tuning fork, the examiner checks light touch, pain, and vibration sense in the toes, feet, fingers, and hands. Loss of vibration and position sense in the feet is typical in CMT and supports the diagnosis of a sensory neuropathy.NCBI -
Romberg test (standing with eyes closed)
The person stands with feet together, first with eyes open, then eyes closed. If they sway or fall when the eyes are closed, this suggests loss of position sense from sensory nerve damage. -
Heel-to-toe walking test
The person walks in a straight line, placing one foot directly in front of the other. Difficulty with this test can show balance problems from sensory loss and weakness. -
Simple hand function tasks
The clinician may ask the person to button a shirt, write, or pick up small objects. These simple tasks show real-life effects of hand weakness and can help track change over time.
Lab and Pathological Tests
-
Routine blood tests to exclude other causes
Blood tests for blood sugar (or HbA1c), vitamin B12, thyroid function, kidney and liver function help rule out acquired causes of neuropathy such as diabetes, vitamin deficiency, thyroid disease, or kidney failure. This is important so doctors do not miss a treatable cause.NCBI -
Targeted genetic test for GJB1 mutation
A DNA test is done from a blood sample or saliva. The laboratory reads the GJB1 gene to look for known or new mutations. Finding a clearly harmful GJB1 mutation in a person with matching symptoms confirms the diagnosis of CMTX1.NCBI+2Johns Hopkins University+2 -
Broader CMT gene panel or exome sequencing
If the first test is negative or if the picture is unclear, doctors may order a panel testing many CMT genes at once, or even exome sequencing. This helps to rule out other CMT types and may still identify a GJB1 mutation that was missed by older methods.NCBI+1 -
Nerve biopsy (sural nerve biopsy)
In rare cases, a small piece of nerve from the lower leg is removed and examined under a microscope. Doctors look for changes in myelin and axons that match hereditary neuropathy. Today, this test is used far less often because genetic testing is safer and more specific.NCBI -
Cerebrospinal fluid (CSF) analysis
Sometimes a lumbar puncture is done to check the fluid around the brain and spinal cord. This helps rule out inflammatory neuropathies (like CIDP) that can mimic CMT. In CMTX1, CSF is usually normal or only mildly changed.NCBI
Electrodiagnostic Tests
-
Nerve conduction studies (NCS)
This test uses small electrical pulses on the skin over nerves to measure how fast and how strong signals travel. In CMTX1, conduction velocities are usually in an intermediate range (not as slow as many demyelinating forms, and not completely normal), and they may be somewhat different between nerves. These patterns, together with symptoms and family history, strongly support CMTX1.PMC+2Experts in CMT+2 -
Electromyography (EMG)
A very thin needle is placed into muscles to record electrical activity. EMG shows whether muscles have lost their nerve supply and whether there are signs of chronic denervation and re-innervation, which are typical in long-standing neuropathy.PMC+1 -
Repetitive nerve stimulation (to exclude other disorders)
This test repeatedly stimulates a nerve to look for changes that suggest a neuromuscular junction disease (like myasthenia gravis). It is usually normal in CMTX1, but doing it can help doctors rule out other conditions when the diagnosis is uncertain. -
Somatosensory evoked potentials (SSEPs)
A mild stimulus is applied to a nerve in the arm or leg, and brain responses are recorded. SSEPs can show how well signals travel through both peripheral nerves and central pathways. In some CMTX1 patients with CNS involvement, these responses can be delayed.PMC+1
Imaging Tests
-
MRI of the brain
Brain MRI is usually normal in classic CMTX1. However, in patients with stroke-like episodes, MRI can show temporary or fixed white-matter changes. These changes help doctors understand that the GJB1 mutation is also affecting the brain, not just the peripheral nerves.Frontiers+1 -
Nerve ultrasound or MRI of peripheral nerves
High-resolution ultrasound or MRI can show the size and structure of peripheral nerves. In hereditary neuropathies, nerves may be enlarged in a characteristic pattern. While not specific for CMTX1, these imaging tests can support the diagnosis and help distinguish inherited from acquired neuropathies.Springer Nature Link+1
Non-pharmacological (non-drug) treatments
Each of these is “supportive care”. Together, they are the main treatment for CMTX1 today. PMC+2Muscular Dystrophy Association+2
-
Targeted physical therapy
Physical therapy uses safe exercises to keep muscles as strong and flexible as possible. A therapist will design a program with stretching, gentle strengthening, and balance work, matched to your weakness level. The main purpose is to slow muscle wasting, prevent stiff joints, and reduce falls. It works by regularly activating nerves and muscles, helping them stay active and coordinated even when the underlying disease slowly progresses. Physiopedia+1 -
Stretching and range-of-motion exercise
Daily stretching of ankles, knees, hips, and toes helps keep joints moving freely. In CMTX1, uneven muscle strength can pull joints into awkward positions, causing contractures (frozen joints). The purpose of stretching is to keep tendons long and joints flexible so walking and standing stay easier. Mechanically, slow controlled stretch reduces stiffness in muscles and connective tissue and prevents shortening over time. Mayo Clinic+1 -
Strengthening of core and proximal muscles
Even when feet and hands are weak, muscles around the hips, shoulders, and trunk can be trained. The purpose is to build a “strong center” so you can compensate for weaker lower-leg muscles. Strengthening works by repeated resistance exercise, which encourages remaining motor units to become more efficient and improves posture and balance. Lippincott Journals+1 -
Aerobic, low-impact exercise
Activities like cycling, swimming, or gentle walking protect the joints but still raise heart rate. The purpose is to maintain heart and lung fitness and reduce fatigue. The mechanism is simple: regular aerobic activity improves blood flow, oxygen delivery to tissues, and general endurance, which helps you do more before feeling tired. Mayo Clinic+1 -
Occupational therapy (OT)
Occupational therapists focus on hand function and everyday tasks like dressing, writing, typing, and cooking. Their purpose is to help you stay independent by teaching energy-saving tricks and suggesting adaptive tools (special pens, grips, button hooks). This works by matching your environment and tools to your actual hand strength and coordination, so tasks need less effort. Charcot-Marie-Tooth Association+1 -
Ankle-foot orthoses (AFOs)
AFOs are light braces worn inside or over shoes to hold the ankle and foot in a good position. For people with foot drop, they stop the toes from catching on the ground. The purpose is safer walking with fewer falls. Mechanically, AFOs support weak muscles, keep the ankle at a stable angle, and improve the step pattern. Dove Medical Press+1 -
Custom shoes and insoles
Special shoes or insoles can support high arches, claw toes, and unstable ankles. The purpose is to reduce pressure points, pain, and skin breakdown. They work by spreading weight evenly across the foot and supporting unstable joints, so walking is more comfortable and safer. Wikipedia+1 -
Walking aids (canes, crutches, walkers)
Some people with CMTX1 need extra support for balance or longer distances. The purpose is to reduce falls and save energy. Mechanically, walking aids widen your base of support and let your arms share some of the work with your legs, which improves stability and confidence. PMC+1 -
Hand splints and wrist supports
Soft or rigid splints can support weak wrists and fingers. The purpose is to improve grip, prevent deformity, and reduce pain from overuse. Splints work by holding joints in neutral, efficient positions so muscles do not have to work as hard to maintain posture. PMC+1 -
Podiatry (foot-care) visits
Regular visits to a podiatrist help manage calluses, nail problems, and pressure sores caused by abnormal foot shape and altered walking. The purpose is to prevent wounds and infections that can limit mobility. Mechanistically, careful trimming and protective padding reduce friction and pressure on vulnerable skin. Wikipedia+1 -
Pain psychology and cognitive-behavioural therapy (CBT)
Long-term pain and fatigue can lead to anxiety or low mood. Pain-focused CBT teaches coping skills, pacing, and relaxation. The purpose is to reduce the emotional “weight” of pain and improve quality of life. It works by changing how the brain interprets pain signals and by breaking the cycle of fear, avoidance, and worsening disability. ScienceDirect+1 -
Energy-conservation and pacing strategies
OT and rehab teams teach people to break tasks into smaller steps, rest before exhaustion, and plan the day. The purpose is to reduce fatigue and allow more activities overall. The mechanism is mostly behavioural: by balancing effort and rest, muscles and nerves are not constantly over-stressed, so you can keep going longer. PMC+1 -
Home safety modifications
Simple changes such as grab bars, non-slip mats, ramps, and good lighting make moving around safer. The purpose is fall prevention. These modifications work by reducing environmental hazards, so balance problems and foot drop are less likely to cause serious injury. ResearchGate+1 -
Vocational rehabilitation and school/work accommodations
Specialists help adjust work or school settings—such as flexible schedules, ergonomic desks, or speech-to-text software. The purpose is to protect long-term employment or education. This works by matching job demands to the person’s physical capacity, avoiding overuse and burnout. PMC+1 -
Psychological counselling and peer support groups
Living with a chronic genetic disease can feel lonely. Counselling and support groups provide a safe place to talk, share tips, and reduce depression or anxiety. The purpose is emotional resilience. This works by strengthening coping skills and social support, both of which are known to improve quality of life in CMT. PMC+1 -
Respiratory and sleep assessment (when needed)
Most people with CMTX1 do not have major breathing problems, but some may develop sleep-related breathing issues. The purpose of screening is to catch problems early and treat them with devices like CPAP if needed. The mechanism is early detection of weak breathing muscles or obstructed airways so oxygen levels stay safe during sleep. UpToDate+1 -
Nutritional counselling
A dietitian can help you stay at a healthy weight. Extra weight makes walking much harder on weak muscles and unstable feet. The purpose is to protect joints and maintain mobility. It works by combining balanced nutrition with realistic activity levels, helping you avoid both under-nutrition and obesity. MDPI+1 -
Avoidance of nerve-toxic medicines
Certain drugs, such as the chemotherapy agent vincristine, are known to damage peripheral nerves and should be avoided in CMT when possible. The purpose is to prevent sudden worsening. Mechanistically, these medicines injure myelin or axons, so people with already fragile nerves are at higher risk of severe damage. Wikipedia+1 -
Genetic counselling
Genetic counsellors explain how CMTX1 is inherited (X-linked), discuss testing of relatives, and help with family-planning decisions. The purpose is informed choice and emotional support. The mechanism is education: when families understand risk patterns and options, they can plan pregnancies and testing in a less stressful, more controlled way. American Academy of Neurology+1 -
Participation in clinical trials and registries
Joining patient registries and, when appropriate, clinical trials helps researchers test new treatments like gene therapy. The purpose is to expand future options while providing careful monitoring. Clinical trials work by comparing experimental treatments with standard care under strict safety rules, generating the evidence needed for future approvals. CMT Research Foundation+2AFM Téléthon+2
Drug treatments
Important: No medicine is currently approved to cure or slow CMTX1 itself. Drugs are used to manage pain, cramps, mood, and sleep, borrowing evidence from other neuropathic pain conditions such as diabetic peripheral neuropathy and postherpetic neuralgia. Always follow your neurologist’s advice; do not start or stop medicines on your own. ScienceDirect+2MDPI+2
Below, “typical doses” are general adult ranges, not personal prescriptions.
-
Gabapentin
Gabapentin (brand example NEURONTIN/GRALISE) is an anti-seizure drug widely used for chronic nerve pain. FDA labels show it is approved for postherpetic neuralgia and helps with neuropathic pain in several studies. Typical adult pain doses range from about 900–3600 mg per day in divided doses. It acts on calcium channels in nerve cells, reducing abnormal firing and lowering pain signals, but may cause dizziness, sleepiness, and swelling. FDA Access Data+3FDA Access Data+3FDA Access Data+3 -
Pregabalin
Pregabalin (LYRICA) is similar to gabapentin but more potent and predictable. FDA labeling shows approval for neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and neuropathic pain after spinal cord injury. Usual adult doses range from 150–600 mg per day in 2–3 doses. It lowers calcium entry into nerve endings, which reduces release of pain neurotransmitters. Common side effects include dizziness, sleepiness, weight gain, and swelling of the legs. FDA Access Data+3FDA Access Data+3FDA Access Data+3 -
Duloxetine
Duloxetine (CYMBALTA) is an antidepressant that also treats neuropathic pain, including diabetic peripheral neuropathy and fibromyalgia. Typical adult neuropathic pain doses are about 60–120 mg once daily. Duloxetine blocks re-uptake of serotonin and norepinephrine, which strengthens descending pain-control pathways in the spinal cord. Side effects can include nausea, dry mouth, constipation, sweating, and sleepiness. FDA Access Data+3FDA Access Data+3FDA Access Data+3 -
Amitriptyline
Amitriptyline is a tricyclic antidepressant often used at low bedtime doses (for example, 10–75 mg) to help nerve pain and sleep. It blocks re-uptake of serotonin and norepinephrine and also has direct effects on sodium channels in nerves, which calms pain signaling. Side effects can include dry mouth, constipation, blurry vision, and drowsiness, so doses must be adjusted carefully. ScienceDirect+1 -
Nortriptyline
Nortriptyline is another tricyclic with similar benefits but often fewer sedating effects than amitriptyline. Typical adult doses for neuropathic pain are around 25–100 mg at night, adjusted slowly. It acts on monoamine re-uptake and sodium channels, reducing nerve excitability. Side effects include dry mouth, constipation, and possible heartbeat changes, so ECG monitoring may be needed in some patients. ScienceDirect+1 -
Venlafaxine
Venlafaxine is an SNRI antidepressant that can help some people with neuropathic pain when first-line drugs fail. Doses for pain often range between 75–225 mg daily. It increases serotonin and norepinephrine activity in descending pain-control pathways. Side effects can include nausea, insomnia, sweating, elevated blood pressure, and withdrawal symptoms if stopped suddenly. ScienceDirect+1 -
Tramadol
Tramadol is an opioid-like pain medicine used only when other medicines do not control pain. FDA labels warn about risks of addiction, overdose, and serious breathing problems. Usual adult doses depend on formulation, often 50–100 mg every 4–6 hours as needed, not exceeding recommended daily limits. It works by weak opioid receptor action and by blocking serotonin and norepinephrine re-uptake. Side effects include nausea, dizziness, constipation, and seizure risk at high doses. FDA Access Data+3FDA Access Data+3FDA Access Data+3 -
Tapentadol
Tapentadol is a stronger prescription painkiller that combines opioid activity with norepinephrine re-uptake inhibition. It is used for severe chronic pain when other options fail. Doses are carefully chosen by doctors and may be given as extended-release tablets. It lowers pain signals at spinal opioid receptors and boosts descending inhibitory pathways. Risks include dependence, constipation, drowsiness, and respiratory depression. Medscape+1 -
Topical lidocaine patches
These patches deliver local anesthetic directly to painful skin areas, such as very sensitive feet. They are usually worn for up to 12 hours in a 24-hour period. The purpose is to numb superficial nerves without major whole-body side effects. Lidocaine blocks sodium channels in nerve endings, so they cannot fire and send pain signals. Skin irritation is the most common problem. ScienceDirect+1 -
Topical capsaicin cream or high-dose patches
Capsaicin, from chili peppers, can reduce nerve pain when applied regularly. Low-strength creams are used several times a day; high-dose patches are applied in clinic. Capsaicin over-stimulates pain fibers and then makes them temporarily less sensitive, reducing burning sensations. It may cause strong burning at first and is used under medical guidance. ScienceDirect+1 -
Simple pain relievers (paracetamol/acetaminophen)
Paracetamol can help mild aches and muscle soreness, especially when taken at regular, safe doses (usually up to 3–4 g/day in adults, depending on local guidelines). It works mainly in the brain to reduce pain and fever, though its exact mechanism is still not fully clear. Overdose can damage the liver, so daily limits are important. UpToDate+1 -
Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen
NSAIDs are useful for joint or muscle pain from overuse or deformities, though they do not treat nerve pain directly. Ibuprofen and naproxen are taken with food at the lowest effective dose for the shortest time. They block COX enzymes and lower prostaglandin production, which reduces inflammation and pain. They can irritate the stomach, raise blood pressure, and affect kidneys with long-term use. UpToDate+1 -
Baclofen
Baclofen is a muscle relaxant that can reduce painful cramps and spasticity in some neuropathies. Doses are increased slowly to avoid drowsiness and weakness. It acts on GABA-B receptors in the spinal cord, lowering excitability of motor neurons. Side effects include fatigue, dizziness, and risk of severe withdrawal symptoms if stopped suddenly. ScienceDirect+1 -
Tizanidine
Tizanidine is another muscle relaxant that reduces spasm by acting on alpha-2 receptors in the spinal cord. It is usually taken several times a day, with dosing adjusted according to effect and side effects. It can help ease muscle tightness and improve comfort. Common side effects are drowsiness, low blood pressure, and dry mouth. ScienceDirect+1 -
Clonazepam (for severe tremor or cramps)
Clonazepam is a benzodiazepine that calms excessive nerve firing. In some people with neuromuscular conditions, low doses at night can reduce muscle jerks or tremor, which may help sleep. It works by enhancing GABA, a calming brain chemical. However, it can cause dependence, sleepiness, and falls, so long-term use is limited. UpToDate+1 -
Selective serotonin re-uptake inhibitors (SSRIs) for depression/anxiety
Medicines like sertraline or fluoxetine do not directly treat nerve damage but can greatly improve mood and coping with chronic illness. Doses vary by drug. They increase serotonin levels in the brain, which helps stabilise mood and anxiety. Side effects include stomach upset, sleep changes, and sexual problems, but they are often better tolerated than older antidepressants. ScienceDirect+1 -
Sleep aids (short-term, under supervision)
In some cases, doctors may prescribe short-term sleep medicines for severe insomnia related to pain or anxiety. The purpose is to restore a normal sleep pattern, which itself reduces pain sensitivity. These drugs act on brain receptors that control sleep–wake cycles. Because of dependence and tolerance risks, they are used with great caution. UpToDate+1 -
Anti-spasmodic agents for bladder or gut issues (when present)
Some people with neuropathies develop bladder urgency or bowel cramps. Anti-spasmodic medicines reduce smooth-muscle over-activity. They work by blocking muscarinic receptors or other pathways that cause involuntary contractions. Dose and choice depend on the exact symptom pattern and must be guided by a specialist. UpToDate+1 -
Anti-emetics for medicine-related nausea
When neuropathic pain drugs cause nausea, doctors may give short-term anti-emetic medicines. These act on dopamine or serotonin receptors in the brain’s vomiting center. The purpose is to allow people to continue effective pain treatment while limiting nausea and vomiting. FDA Access Data+1 -
Medication for co-existing conditions (e.g., diabetes, thyroid disease)
Controlling other medical problems that stress the nerves is also part of treatment. For example, good diabetes or thyroid control can help protect remaining nerve function. The mechanism is simple: less metabolic stress means slower additional nerve damage on top of CMTX1. MDPI+1
Dietary molecular supplements
These supplements do not cure CMTX1. Evidence is mixed, and they should be used only with a doctor’s approval, especially if you also take prescription medicines. MDPI+1
-
Vitamin B12 (methylcobalamin) – Supports normal myelin and red-blood-cell production. Low B12 can worsen nerve damage, so correcting deficiency is important. Doctors may use tablets or injections, depending on levels. Mechanism: co-factor in DNA and myelin synthesis.
-
Folate (folic acid / L-methylfolate) – Works with B12 in one-carbon metabolism and may help if levels are low. The function is to support healthy cell division and blood formation. Mechanism: provides methyl groups needed for DNA and neurotransmitter synthesis.
-
Vitamin B1 (thiamine) and benfotiamine – Thiamine-dependent enzymes are important in nerve energy metabolism. Supplementation may help if diet is poor or in people with additional risk factors like diabetes. Mechanism: improves glucose handling and reduces toxic by-products that can damage nerves.
-
Alpha-lipoic acid – An antioxidant used in some countries for diabetic neuropathy. It helps reduce oxidative stress and may slightly improve nerve symptoms in some patients. Mechanism: recycles other antioxidants like vitamins C and E and supports mitochondrial energy production. Wiley Online Library+1
-
Vitamin D – Low vitamin D is common and linked to muscle weakness and low bone density. Correcting deficiency can support muscle function and reduce fracture risk. Mechanism: regulates calcium–phosphate balance and influences muscle fibers and immune cells.
-
Omega-3 fatty acids (fish oil) – EPA and DHA support cell-membrane fluidity and have anti-inflammatory effects. They may improve general cardiovascular health and possibly mild nerve symptoms. Mechanism: converted to anti-inflammatory mediators and incorporated into nerve cell membranes.
-
Coenzyme Q10 (CoQ10) – A mitochondrial co-factor that helps in cellular energy production and acts as an antioxidant. In some neuromuscular disorders, it may support energy metabolism, although data in CMT are limited. Mechanism: shuttles electrons in the mitochondrial respiratory chain.
-
Magnesium – Important for muscle relaxation and nerve function. Correcting low magnesium can help cramps and fatigue. Mechanism: blocks NMDA receptors and stabilizes nerve membranes, reducing over-excitability.
-
Curcumin (from turmeric) – Has antioxidant and anti-inflammatory properties. It may reduce general inflammation and joint discomfort. Mechanism: modulates NF-κB and other inflammatory signalling pathways, though human data in CMT are limited.
-
Probiotics and gut-health nutrients – A healthy gut microbiome may reduce systemic inflammation and improve nutrient absorption. Mechanism: beneficial bacteria help maintain the gut barrier, influence immune function, and support production of vitamins and short-chain fatty acids. MDPI+1
Regenerative and stem-cell-related therapies / immunity-boosting drugs
At present, no regenerative or stem-cell drug is approved for CMTX1. The options below are in research or early clinical stages, usually in animal models. Doses are experimental and set only within clinical trials. AFM Téléthon+4PMC+4MDPI+4
-
AAV-based GJB1 gene therapy (AAV9)
Scientists have used adeno-associated virus (AAV9) to deliver a healthy GJB1 gene into Schwann cells in CMT1X mouse models. This improved movement and nerve conduction in animals. Mechanism: introduces a working copy of the connexin-32 gene into support cells so they can rebuild healthier myelin. Human trials are still being planned and dosing is experimental. Nature+1 -
AAVrh10-hMPZ.GJB1 gene therapy
A newer vector, AAVrh10-hMPZ.GJB1, has shown positive results in CMTX1 mice after a single intrathecal injection, improving muscle strength and nerve conduction. The aim is long-lasting expression of connexin-32 in Schwann cells. Mechanism: the viral vector carries GJB1 under a myelin protein promoter, targeting the correct cells. This remains pre-clinical and not yet available in routine care. Institut Myologie+1 -
Lentiviral GJB1 gene replacement
Earlier studies used lentiviral vectors carrying GJB1, injected into the spinal fluid of Cx32-null mice, and showed improvement in demyelinating neuropathy. Lentiviral vectors integrate into the host genome, providing potentially long-lasting expression, but also raise concerns about insertional mutagenesis. At present, this approach is still experimental. PMC+1 -
Small-molecule therapies targeting myelin and axonal health
Several small molecules are under investigation in broader CMT (for example, agents that modify myelin lipid metabolism or mitochondrial function). Mechanism: they try to restore cellular pathways disturbed by the genetic defect. For CMTX1, candidate drugs may aim to improve gap-junction function or protect axons from secondary damage. Human data are still limited. MDPI+1 -
Stem-cell–based nerve repair (research stage)
Experimental work is exploring transplantation of Schwann-like cells or mesenchymal stem cells to support damaged peripheral nerves. The idea is that these cells could provide trophic factors and possibly help remyelination. Mechanism: transplanted cells secrete growth factors and form supportive structures around axons. So far, this remains in animal or very early human research and is not standard treatment. MDPI+1 -
Immune-modulating therapies (mainly for other neuropathies)
Drugs such as intravenous immunoglobulin (IVIG) or steroids are helpful in autoimmune neuropathies but are not standard for genetic CMTX1. Sometimes they are tried if there is suspicion of an overlapping immune process. Mechanism: they calm abnormal immune attacks on myelin. For pure CMTX1, routine use is not supported by current evidence. ScienceDirect+1
Surgeries (Procedures and why they are done)
Surgery in CMTX1 does not fix the gene problem but can correct deformities that cause pain and disability. Wikipedia+2Taylor & Francis Online+2
-
Foot osteotomy
In osteotomy, the surgeon cuts and repositions bones in the foot to correct high arches or severe deformities. The goal is a more plantigrade, stable foot. This reduces pain, improves shoe fit, and makes walking safer. -
Tendon transfer procedures
Tendon transfers move a working tendon from a stronger muscle to replace the function of a weaker one (for example, to help lift the foot). The purpose is to restore balance around joints and improve active movement, which can reduce the need for braces. -
Arthrodesis (joint fusion)
When joints are severely unstable or painful, surgeons may fuse them in a functional position. In the foot, ankle or hindfoot fusion can create a solid, stable platform for walking. The trade-off is loss of motion, but pain and instability decrease. -
Plantar fascia release
Tight plantar fascia under the foot can add to high-arch deformity and pain. Partial release surgery loosens this structure to allow the arch to flatten slightly and reduce tension. This can improve comfort and make orthotics more effective. -
Spinal surgery (for scoliosis or severe deformity)
Some people with CMT develop spinal curvature that causes pain or breathing problems. Spinal fusion or other corrective surgery aims to straighten and stabilise the spine. This can improve posture, sitting balance, and sometimes lung function, although it is major surgery and used only when clearly needed.
Prevention and lifestyle
These steps do not stop the gene defect but can slow extra damage and protect function. MDPI+2Mayo Clinic+2
-
Keep a healthy body weight to reduce strain on weak muscles and joints.
-
Do regular gentle exercise (stretching, strength, and low-impact cardio) as advised by a therapist.
-
Avoid nerve-toxic medicines like vincristine unless absolutely necessary and closely supervised.
-
Wear protective footwear and orthoses consistently to prevent falls and foot injuries.
-
Check feet daily for sores, calluses, or pressure spots and treat small problems early.
-
Stop smoking and limit alcohol, as both can worsen nerve damage.
-
Manage other medical conditions such as diabetes, thyroid disease, or vitamin deficiencies.
-
Use good ergonomics at school or work to avoid repetitive stress on weak muscles.
-
Maintain vaccinations and general infection prevention, because severe infections can cause setbacks in strength and mobility.
-
Stay in regular contact with a neuromuscular clinic so treatment can be adjusted as the disease changes.
When to see doctors
You should be reviewed regularly by a neurologist or neuromuscular clinic, even if symptoms feel stable. Extra visits are important if you notice:
-
New or rapidly worsening weakness, balance problems, or frequent falls.
-
Sudden changes in sensation, such as burning, numbness, or severe electric-shock pain.
-
New foot wounds, infections, or big changes in foot shape.
-
Serious side effects from medicines (strong dizziness, mood changes, suicidal thoughts, severe stomach or liver symptoms). UpToDate+1
-
Breathing problems, morning headaches, loud snoring, or very poor sleep.
-
New spine curvature, back pain, or problems sitting or walking.
Because CMTX1 is X-linked, family members may also need genetic counselling and assessment if they have symptoms or plan a pregnancy. American Academy of Neurology+1
What to eat and what to avoid
Diet plans should always be personalized with a doctor or dietitian, especially if you have other illnesses. MDPI+1
-
Eat: colourful vegetables and fruits
These provide vitamins, minerals, and antioxidants that support general tissue repair and immune health. -
Eat: lean proteins
Foods like fish, eggs, poultry, legumes, and tofu give amino acids for muscle maintenance. -
Eat: whole grains
Brown rice, whole-wheat bread, and oats give steady energy and fibre, helping you stay active without big sugar swings. -
Eat: healthy fats
Include small amounts of nuts, seeds, olive oil, and fatty fish rich in omega-3s to support cell membranes and reduce inflammation. -
Eat: calcium and vitamin D sources
Dairy products, fortified plant milks, and safe sunlight exposure help maintain strong bones, which is vital if your gait is unstable. -
Avoid: excessive sugary drinks and sweets
These add weight without nutrition and can worsen blood sugar control, which is bad for nerves. -
Avoid: heavy alcohol intake
Alcohol can be directly toxic to nerves and muscles, so limiting or avoiding it protects remaining nerve function. -
Avoid: crash diets and severe calorie restriction
Rapid weight loss can cause muscle loss and more weakness. Focus on slow, balanced changes. -
Avoid: very salty processed foods
High salt can raise blood pressure and worsen swelling, which some drugs (like pregabalin) already increase. -
Avoid: unproven “miracle cures”
Be careful with expensive supplements or extreme diets claiming to cure CMT. There is no proof they work, and some may interact with your medicines. Always check with your doctor first. MDPI+1
Frequently asked questions (FAQs)
-
Is CMTX1 curable?
No. At this time, there is no cure for CMTX1. Treatment focuses on supportive care: physical and occupational therapy, orthoses, surgery for deformities, and symptom-based drug therapy. Research in gene therapy is promising in animals but not yet routine in humans. Institut Myologie+3PMC+3MDPI+3 -
Can exercise make CMTX1 worse?
Safe, well-planned exercise usually helps rather than harms. Over-exertion, heavy lifting, or high-impact sports may cause fatigue or injuries, but regular gentle stretching, strengthening, and low-impact cardio can preserve function and reduce contractures. A physiotherapist should guide the plan. Lippincott Journals+1 -
Why do I need orthoses if I can still walk?
Braces such as AFOs keep your foot in a stable position and prevent trips from foot drop. They may feel strange at first, but they reduce falls, protect joints, and often delay the need for surgery. Even people who can walk without them sometimes walk better and longer with them. Dove Medical Press+1 -
Will my symptoms always get worse?
CMTX1 is usually slowly progressive, but the speed varies. Many people remain able to walk for decades. Good rehab, safe activity, and avoidance of extra nerve damage can make a big difference in day-to-day life, even though the underlying gene change stays the same. Taylor & Francis Online+1 -
Can women be affected if the disease is X-linked?
Yes. Women who carry the GJB1 mutation can have symptoms, but they are often milder than in men. Some women may only have subtle signs, while others may develop clear weakness and sensory changes. Genetic counselling helps clarify risks to children. Wikipedia+1 -
What age do symptoms usually start?
CMTX1 often begins in late childhood or teenage years, with clumsiness, ankle sprains, or difficulty running. However, some people present earlier or later. A confirmed diagnosis requires clinical exam, nerve conduction tests, and genetic testing. American Academy of Neurology+1 -
Is pain common in CMTX1?
Many people mainly notice weakness and balance problems, but some develop neuropathic pain described as burning, tingling, or stabbing. Pain is usually managed with neuropathic pain medicines (like gabapentin, pregabalin, or duloxetine), physical therapy, and psychological strategies. FDA Access Data+4ScienceDirect+4MDPI+4 -
Can diet alone treat CMTX1?
No. A healthy diet supports your general health and muscles but cannot correct the GJB1 mutation. Nutritional care is still important to avoid weight gain, vitamin deficiency, and other problems that make symptoms worse. Supplements should always be discussed with a doctor. MDPI+1 -
Are stem-cell therapies available now?
At the moment, stem-cell or regenerative therapies for CMTX1 are still in the research phase, mainly in animal models or very early human studies. They should only be accessed through properly approved clinical trials, not through unregulated “stem-cell clinics”. Nature+2PMC+2 -
Can I have children if I have CMTX1?
Many people with CMTX1 have children. Because the condition is X-linked, sons and daughters have different risk patterns depending on whether the mother or father is affected. Genetic counselling can explain options like prenatal testing or pre-implantation genetic testing. American Academy of Neurology+1 -
How often should I see my neurologist?
This varies, but many people are reviewed every 6–12 months, plus extra visits if symptoms change quickly, new pain appears, or new treatments are considered. A multidisciplinary team (neurologist, physiatrist, PT, OT, orthotist, psychologist) gives the best long-term care. PMC+1 -
Is it safe to have surgery or anaesthesia with CMTX1?
Most people with CMT can safely have surgery when anaesthesiologists know about the condition and avoid certain neurotoxic agents. Pre-operative assessment looks at breathing, heart status, and existing weakness. Post-operative rehab is especially important to regain function. UpToDate+1 -
What about school and sports for children with CMTX1?
Children can usually attend regular school with some physical adaptations, such as extra time between classes, elevator access, or modified PE activities. Low-impact sports like swimming or cycling are often better than high-impact running or jumping. Early therapy support helps build safe habits. PMC+1 -
Are there international guidelines for treatment?
Yes. Recent practice guidelines and reviews emphasise that rehabilitation, orthotics, and surgery (when needed) are the core of management, with drugs mainly for pain and mood. They stress multidisciplinary care and regular follow-up rather than a single “magic pill.” ResearchGate+2MDPI+2 -
What can I do today to help myself?
Simple daily steps—gentle stretching, safe walking or cycling, using your braces, checking your feet, eating balanced meals, sleeping enough, and staying connected with your care team—can all improve how you feel and move. While they cannot remove the gene change, they can greatly improve your comfort, independence, and hope for the future. Mayo Clinic+2MDPI+2
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 31, 2025.